เข้าระบบ

ชื่อผู้ใช้

รหัสผ่าน

  ล ง ท ะ เ บี ย น  

RegenaStukes

RegenaStukes的บล๊อก

RegenaStukes的主頁 | ดูทั้งหมด

Cbd Oil

คำค้น:cannabis  oil  2022-06-02 23:44
BRITISH CANNABIS, a private Cannabidol producer, is the current leader in the UK’s CBD sweepstakes. A total of 310 products that are associated with British cannabis oil were recently improved to regulators This has been revealed by an analysis of a list published earlier this month by Food Standards Agency (FSA).

The preliminary approval was granted to 75 products that were submitted by the Berkshire-based business, and 235 submitted jointly with other businesses. FSA preliminarily approved 3,536 items as new or novel foods according to the table, which was published on March 31

RX Pharmatech Ltd. from Bradford, West Yorkshire has 273 products approved by it. This is the second-highest number. RX Pharmatech submitted 116 product independently and 157 together with other producers.
According to the Association for the Cannabinoid Industry. (ACI), the UK market for CBD products was worth PS690million. According to ACI, CBD sales in the UK more than doubled between 2019 and 2021, this makes the UK the second-largest consumer market outside of the USA.

cbd fsa eligible



Companies remaining
In total, 374 companies had products approved by the FSA. Some companies applied separately; others were only participants in joint applications filed with other producers. Other companies also filed independent applications. Some filed separately while others filed jointly There were 70 CBD applications submitted to the FSA.
The products on the list can be sold, but those that fail FSA inspection are not compliant and must be removed. FSA stressed that approvals are preliminary, some products may be removed during the later stages of their review.
Many of these products were promoted to pre-validation status ("awaiting proof"), the second phase of FSA's novel product approval process. FSA has now approved 57 products from five companies.

Seeking clarity
FSA's novel food approval process is first and foremost aimed at clarifying the gray market for CBD products that have appeared in stores over many years. The products must have been in circulation before February 13, 2020 to be eligible for agency consideration. All products that were introduced after this date are not eligible for consideration.

According to the Association's website, BRITISH CANNABIS products were likely obtained through a consortium that was organized by the ACI. ACI declined to provide information on the number of products that were sent through its consortium. It also refused to disclose the names or numbers of the applicants (FPs) submitted by the companies. ACI's members list at least 628 products, which includes British Cannabis, among those that advanced.

Applications of EIHA
RX Pharmatech was submitted products by a separate consortium to the European Industrial Hemp Association.
EIHA Projects GmbH included 193 companies in its submissions of products. The EIHA saw 1,992 CBD products preliminarily approve, accounting for about 56% These products were part of two EIHA applications that covered isolates (1.157) and full spectrum extracts (835).

A quick look at the top companies
Below are the top five companies, ranked by the number of products each company had approved by FSA.


British Cannabis
BRITISH CANNABIS was established in 2015. It is an independent, vertically integrated producer and distributor of cannabis, CBD, and other cannabinoid-rich products.The company supplies white-label brands with its own brand products. BRITISH CANNABIS operates its own laboratory, manufacturing facility and warehouse, the company also has dispatch operations and a farm for cannabis research in Portugal. The company claims that it has shipped more than 50k bottles of CBD oils between its two largest white label clients. BRITISH CANNABIS announced in September 2021 it was planning to invest in a new facility. The facility will have an ISO-accredited lab (British Cannabis Analytics), as well as a cosmetics line. This could increase its potential capacity by up to three times. One of the 35 UK government "chemist rings trial" testing labs is used to measure Cannabidol and cannabinoid levels in commercial products.

Associated principals : Thomas Whettem CEO & Founder, David Ralston, Managing director

RX Pharmatech Ltd
RX Pharmatech Ltd. has very little information available, it apparently doesn't have a website. reported by other sources, the company was founded in May 2016. RX Pharmatech is a supplier for bulk isolates, and distillates produced by GVB Biopharma in Las Vegas, Nevada, USA. RX Pharmatech have also been a party the second-highest FSA product list. GVB also claimed in a press statement April 7, 2022, that it is the largest supplier to white label formulas for oral tinctures and vape liquids. GVB stated that it sources raw materials from an American farmers cooperative. GVB's website says that the company has an office in the UK, based in Doncaster Yorkshire, England. GVB has one investor: Decathlon Kapital Partners, a growth equity business based out of Park City, Utah. GVB claims to also have operations in Europe (location unknown) and Bogota in Colombia. GVB Biopharma has joined Medicaleaf Ltd. in Cheltenham and Gloucestershire, as well as Isomist Ltd. in London, to submit three products for FSA approval. GVB Biopharma, is being reported to be under a strategic alliance with Sonder Fulfillment. Sonder Fulfillment a division Golden Triangle Ventures, a Las Vegas-based pennystock company.

Principals associated with RX Pharmatech Ltd. Dominic James Bartle is the director and Damien Jonathan Bove is the director. GVB Biopharma Phillip Swindells is the CEO and co-founder. Jack Feldman is president & Co-founder. Hugh Kinsman is CFO.

Mile High Labs
Mile High Labs, a supplier of CBD and CBN in Colorado, is located in Broomfield. Mile High reported that in 2019, it raised $100 million through two rounds of funding, including $65 million from MGG Investment Group, New York (2019). Mile High uses raw materials sourced from the USA's contracted CBD hemp growers to create an extraction facility. According to its website, the company also has a Belfast, Northern Ireland office.

Associated principals Jonathan Hilley CEO, Ryan Keeler COO, Jodi Gatica VP Quality, Danny Moses, Investor.

Taylor Mammon Ltd
Taylor Mammon Ltd. claims to be a white-label manufacturer, and CBD distributor. It is located in Welwyn Garden City. The company operates under the parent company, Kentucky-based GenCanna. OGGUSA Inc. was also known as GenCanna. In May 2020, GenCanna's majority of assets were sold to MGG Investment Group in New York. MGG Investment Group is a private direct lender, and one of GenCanna’s creditors. GenCanna acquired Taylor Mammon and UK's CBD Capital last year.

Associated principals : Taylor Mammon - Alex Taylor, cofounder; James Taylor chief commercial officer; Nathan Wogman cofounder and managing director. GenCanna/OGGUSA Inc. - Andrew Barnett, CEO; Hassan Akhtar, managing director, Europe.

Sativa Wellness Group
Goodbody Health Inc is now known. However, it has submitted its novel foods application under Sativa Wellness. The Canada-based company is an OTC trader of around 20 CBD products. These include oils, capsules, gummies and cosmetics. There are also laboratories in the UK and Poland for testing CBD products.There is also a branch in Beckington in Somerset, England. In 2020, when public financial records are available, the company posted a loss in excess of $6.5million (PS5 million). Goodbody shares are currently trading at approximately $0.05 (5cents). Goodbody's UK-based subsidiary, PhytoVista Laboratories was granted a controlled drug license in April 2022.

Associated principals (Goodbody Health Inc.): Geremy Tom, Founder & Executive Chair; Marc Howells CEO; Anne Tew CFO and Corporate Secretary.
แชร์ 1918 ดู | 0 ความเห็น

Footprints

ความเห็น